| Nr. | Year OPEN | Title | users say | rate good | rate bad | no link | Citation |
|---|
PI3KProtein kinase B AktPAR4Phosphatidylinositol phosphateRac Cell migrationARFPIKEEndothelial dysfunctionInsulin resistancep110alphaWortmanninLY294002PI103GDC0941| 1 | 2007 | The phosphoinositide 3-kinase pathway in human cancer: genetic alterations and therapeutic implications. | 
| + | - | nl | Curr Genomics 8(5):271-306 (2007) |
| 2 | 2009 | Take your PIK: phosphatidylinositol 3-kinase inhibitors race through the clinic and toward cancer therapy. |
| + | - | nl | Mol Cancer Ther 8(1):1-9 (2009) |
| 3 | 2008 | Phosphatidylinositol 3-kinase inhibitors: promising drug candidates for cancer therapy. |
| + | - | nl | Cancer Sci 99(9):1734-40 (2008) |
| 4 | 2006 | The phosphoinositide 3-kinase/Akt1/Par-4 axis: a cancer-selective therapeutic target. |
| + | - | nl | Cancer Res 66(6):2889-92 (2006) |
| 5 | 2003 | The phosphoinositide (PI) 3-kinase family. |
| + | - | nl | J Cell Sci 116(Pt 15):3037-40 (2003) |
| 6 | 2001 | Phosphoinositide 3-kinase signalling pathways. |
| + | - | nl | J Cell Sci 114(Pt 8):1439-45 (2001) |
| 7 | 1992 | Phosphatidylinositol 3-kinase: a novel effector. |
| + | - | nl | Cell Growth Differ 3(10):747-52 (1992) |
| 8 | 2001 | Prospects for phosphoinositide 3-kinase inhibition as a cancer treatment. |
| + | - | nl | Endocr Relat Cancer 8(3):237-48 (2001) |
| 9 | 1999 | Phosphoinositide 3-kinases and their FYVE domain-containing effectors as regulators of vacuolar/lysosomal membrane trafficking pathways. |
| + | - | nl | J Biol Chem 274(14):9129-32 (1999) |
| 10 | 1999 | The role of phosphoinositide 3-kinase lipid products in cell function. |
| + | - | nl | J Biol Chem 274(13):8347-50 (1999) |
| 11 | 2007 | Phosphoinositide 3-kinases as a common platform for multi-hormone signaling. |
| + | - | nl | J Endocrinol 194(2):243-56 (2007) |
| 12 | 1998 | PI 3-kinase. |
| + | - | nl | Curr Biol 8(23):R828 (1998) |
| 13 | 2009 | PI3K/PTEN signaling in angiogenesis and tumorigenesis. |
| + | - | nl | Adv Cancer Res 102(-):19-65 (2009) |
| 14 | 2004 | Molecular targeting: PI3 kinase pathway. |
| + | - | nl | Ann Oncol 15 Suppl 4(-):iv233-9 (2004) |
| 15 | 2010 | Status of PI3K inhibition and biomarker development in cancer therapeutics. |
| + | - | nl | Ann Oncol 21(4):683-91 (2010) |
| 16 | 2010 | Somatic mutations in PI3Kalpha: structural basis for enzyme activation and drug design. |
| + | - | nl | Biochim Biophys Acta 1804(3):533-40 (2010) |
| 17 | 2003 | Multiple roles of the PI3K/PKB (Akt) pathway in cell cycle progression. |
| + | - | nl | Cell Cycle 2(4):339-45 (2003) |
| 18 | 2007 | New functions for PI3K in the control of cell division. |
| + | - | nl | Cell Cycle 6(14):1696-8 (2007) |
| 19 | 2009 | Phosphoinositide 3-kinase signalling in the vascular system. |
| + | - | nl | Cardiovasc Res 82(2):261-71 (2009) |
| 20 | 2008 | The regulation of cell motility and chemotaxis by phospholipid signaling. | 
| + | - | nl | J Cell Sci 121(Pt 5):551-9 (2008) |
| 21 | 2010 | Multiple functions of phosphoinositide-3 kinase enhancer (PIKE). |
| + | - | nl | ScientificWorldJournal 10(-):613-23 (2010) |
| 22 | 2008 | An integrated view of insulin resistance and endothelial dysfunction. |
| + | - | nl | Endocrinol Metab Clin North Am 37(3):685-711, ix-x (2008) |
| 23 | 2010 | Targeting the PI3K signaling pathway in cancer. |
| + | - | nl | Curr Opin Genet Dev 20(1):87-90 (2010) |
| 24 | 2009 | PI 3-kinase and cancer: changing accents. |
| + | - | nl | Curr Opin Genet Dev 19(1):12-7 (2009) |
| 25 | 2010 | Drugging the PI3 kinome: from chemical tools to drugs in the clinic. |
| + | - | nl | Cancer Res 70(6):2146-57 (2010) |
